ArticleJournal of clinical immunology2025

Dual Targeted Therapy with Baricitinib and Anifrolumab in Infantile Spondyloenchondrodysplasia with Immune Dysregulation.

Sindhu Pandurangi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.